“Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD”. Swiss Medical Weekly 142, no. 2930 (July 15, 2012): w13628. Accessed December 1, 2025. https://smw.ch/index.php/smw/article/view/1535.